Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. Murray
Observed names:
J H Murray,
J MURRAY,
J Murray,
J.H. Murray
Observed institutions:
Fox Chase Cancer Center,
DuPont (United States),
Howard Hughes Medical Institute,
Nicolaus Copernicus University,
Yale University,
Merrimack Pharmaceuticals (United States),
Institute for Bioscience and Biotechnology Research,
Organon (Netherlands)
show all 8
OpenAlex ID:
A5111019291
Isolation and partial characterization of an antigen-specific T-cell factor associated with the suppression of delayed type hypersensitivity.
1981
·
R W Rosenstein
, J H Murray
, et al.
·
Proceedings of the National Academy of Sciences
·
34
In vitro immunization of human lymphocytes. I. Production of human monoclonal antibodies against bombesin and tetanus toxoid.
1985
·
M K Ho
, N Rand
, et al.
·
The Journal of Immunology
·
33
Affinity-purified antigen-specific products produced by T cells share epitopes recognized by heterologous antisera raised against several different antigen-specific products from T cells
1983
·
R.E. Cone
, R.W. Rosenstein
, et al.
·
Cellular Immunology
·
21
Purification and characterization of TNP-specific immunoregulatory molecules produced by T cells sensitized by picrylchloride (PC1F).
1983
·
W Ptak
, R K Gershon
, et al.
·
The Journal of Immunology
·
20
A phase I/II and pharmacologic study of MM-111 in patients with advanced, refractory HER2-positive (HER2+) cancers.
2010
·
C. S. Denlinger
, M. Beeram
, et al.
·
Journal of Clinical Oncology
·
19
Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibody
1994
·
A. K. Erdi
, B. W. Wessels
, et al.
·
Cancer
·
18
Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine.
1993
·
E Bloemena
, H Gall
, et al.
·
PubMed
·
18
A phase I/II study of MM-111, a novel bispecific antibody that targets the ErB2/ErB3 heterodimer, in combination with trastuzumab in advanced refractory HER2-positive breast cancer.
2011
·
M. J. Higgins
, N. Y. Gabrail
, et al.
·
Journal of Clinical Oncology
·
16
Characterization of T-cell surface proteins bound by heterologous antisera to antigen-specific T-cell products.
1981
·
R E Cone
, R W Rosenstein
, et al.
·
Proceedings of the National Academy of Sciences
·
16
Quantitation of human tumor-reactive monoclonal antibody 16.88 in the circulation and localization of 16.88 in colorectal metastatic tumor tissue using murine antiidiotypic antibodies.
1992
·
W C Taddei-Peters
, M V Haspel
, et al.
·
PubMed
·
8
Distribution and immunochemical characterization of a keratin-like antigen in epithelial tumors using mouse and human monoclonal antibodies.
1988
·
M K Ho
, C Geist
, et al.
·
PubMed
·
7
Abstract P6-15-15: MM-111 - A Novel Bispecific Antibody Targeting HER-2/HER-3 Z Heterodimer: Safety and Tolerability in a First-In Human Phase I/II Study in Patients with Refractory HER2-Positive (HER-2+) Cancers
2010
·
M Beeram
, CS Denlinger
, et al.
·
Cancer Research
·
5
313 A 1/2phase study to evaluate the pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of albuferon™ in the treatment experienced subjects with chronic hepatitis C
2003
·
V BALAN
, M SULKOWSKI
, et al.
·
Hepatology
·
4
Establishment, molecular rescue, and expression of 123AV16-1, a tumor-reactive human monoclonal antibody.
1994
·
B L Hall
, J H Murray
, et al.
·
PubMed
·
4
Preclinical studies of indium-111-labeled IgM: a human monoclonal antibody for infection imaging.
1997
·
R Subramanian
, S Vallabhajoshula
, et al.
·
PubMed
·
3
Characterization of 47D10, a glycoprotein associated with pancreatic carcinoma
1986
·
Mitchell Ho
, Katsuaki KATO
, et al.
·
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
Show more works
View as search
Works count:
16
Citation count:
226
H-index:
9
I10-index:
9
Year
Topic
Type